1. Review and Update: Hematologic Malignancies and Adult Cardiac Surgery
- Author
-
William J Wallisch, Brent Kidd, Brigid C. Flynn, Jared Staab, and Elizabeth Cotter
- Subjects
Adult ,medicine.medical_specialty ,business.industry ,Hemorrhage ,Perioperative ,030204 cardiovascular system & hematology ,Surgical procedures ,medicine.disease ,Lymphoma ,Cardiac surgery ,03 medical and health sciences ,Leukemia ,0302 clinical medicine ,Anesthesiology and Pain Medicine ,030202 anesthesiology ,Hematologic Neoplasms ,Active disease ,Humans ,Medicine ,Cardiac Surgical Procedures ,Cardiology and Cardiovascular Medicine ,Adverse effect ,business ,Intensive care medicine ,Surgical patients - Abstract
As treatments for hematologic malignancies continue to advance, many patients with active disease and many more in remission will present for cardiac surgical procedures. Radiation and chemotherapeutic therapies for hematologic malignancies often result in cardiopulmonary injury. Evidence demonstrates that patients with hematologic malignancies undergoing cardiac surgery are at risk for perioperative adverse events, including bleeding, clotting, infection, and immunomodulation. However, short- and long-term mortality has been found to be acceptable. This review will distinguish the important points of characterizing, understanding, and managing hematologic malignancies in the cardiac surgical patient.
- Published
- 2020